OAM
VRTX icon

Ostrum Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Ostrum Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$626K Sell
1,403
-2,846
-67% -$1.33M 0.04% 284
2025
Q4 		$1.93M Sell
4,249
-1,170
-22% -$504K 0.09% 168
2025
Q3 		$2.12M Sell
5,419
-475
-8% -$199K 0.1% 187
2025
Q2 		$2.62M Sell
5,894
-452
-7% -$208K 0.12% 158
2025
Q1 		$3.08M Sell
6,346
-13
-0.2% -$6.06K 0.16% 118
2024
Q4 		$2.56M Buy
6,359
+1,086
+21% +$503K 0.22% 141
2024
Q3 		$2.45M Sell
5,273
-2,155
-29% -$1.04M 0.2% 180
2024
Q2 		$3.48M Sell
7,428
-1,893
-20% -$822K 0.3% 86
2024
Q1 		$3.9M Buy
9,321
+15
+0.2% +$6.34K 0.31% 85
2023
Q4 		$3.79M Buy
9,306
+477
+5% +$176K 0.33% 80
2023
Q3 		$3.07M Sell
8,829
-60
-0.7% -$21K 0.28% 93
2023
Q2 		$3.13M Buy
8,889
+8
+0.1% +$2.69K 0.26% 120
2023
Q1 		$2.8M Buy
+8,881
New +$2.66M 0.24% 137
2020
Q3 		$3.65M Buy
13,405
+1,010
+8% +$279K 2.35% 12
2020
Q2 		$3.6M Buy
12,395
+1,700
+16% +$461K 2.14% 11
2020
Q1 		$2.54M Buy
10,695
+1,100
+11% +$252K 1.75% 12
2019
Q4 		$2.1M Hold
9,595
– – 1% 22
2019
Q3 		$1.63M Buy
9,595
+900
+10% +$159K 0.81% 30
2019
Q2 		$1.59M Buy
8,695
+5,042
+138% +$881K 0.44% 78
2019
Q1 		$672K Hold
3,653
– – 0.22% 120
2018
Q4 		$605K Buy
+3,653
New +$633K 0.24% 117

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Ostrum Asset Management's VRTX Position: Q1 2026 in Review

Ostrum Asset Management reduced its Vertex Pharmaceuticals (VRTX) stake by 67% in Q1 2026, selling an estimated $1.33M and leaving 1,403 shares worth $626K. The position accounts for 0.04% of the portfolio, ranked #284.

Ostrum Asset Management first reported a position in VRTX in Q4 2018 and has held it in 21 quarters since. The position peaked at $3.9M in Q1 2024. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Ostrum Asset Management held 1,403 shares of Vertex Pharmaceuticals worth $626K as of Q1 2026.
  • Ostrum Asset Management sold 2,846 Vertex Pharmaceuticals shares in Q1 2026, an estimated $1.33M.
  • Vertex Pharmaceuticals made up 0.04% of Ostrum Asset Management's portfolio in Q1 2026, its #284 holding.
  • Ostrum Asset Management first reported a position in Vertex Pharmaceuticals in Q4 2018 and has held it in 21 quarters since.
  • Ostrum Asset Management's Vertex Pharmaceuticals position peaked at $3.9M in Q1 2024.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Ostrum Asset Management's 13F filing for Q1 2026, filed 14 May 2026.